These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9254084

  • 1. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.
    Mathiesen T, Edner G, Ulfarsson E, Andersson B.
    J Neurosurg; 1997 Aug; 87(2):215-20. PubMed ID: 9254084
    [Abstract] [Full Text] [Related]

  • 2. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage.
    Kwon KY, Jeon BC.
    J Korean Med Sci; 2001 Dec; 16(6):774-80. PubMed ID: 11748361
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Early Dynamics of Interleukin-6 in Cerebrospinal Fluid after Aneurysmal Subarachnoid Hemorrhage.
    Ďuriš K, Neuman E, Vybíhal V, Juráň V, Gottwaldová J, Kýr M, Vašků A, Smrčka M.
    J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):145-151. PubMed ID: 28869993
    [Abstract] [Full Text] [Related]

  • 6. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats.
    Kato H, Kawaguchi M, Inoue S, Hirai K, Furuya H.
    Anesth Analg; 2009 Jan; 108(1):288-95. PubMed ID: 19095864
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD.
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
    Galea J, Ogungbenro K, Hulme S, Patel H, Scarth S, Hoadley M, Illingworth K, McMahon CJ, Tzerakis N, King AT, Vail A, Hopkins SJ, Rothwell N, Tyrrell P.
    J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
    [Abstract] [Full Text] [Related]

  • 11. Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients.
    Sun XG, Ma Q, Jing G, Wang L, Hao XD, Wang GQ.
    Neurol Sci; 2017 May; 38(5):873-877. PubMed ID: 28229304
    [Abstract] [Full Text] [Related]

  • 12. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W.
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [Abstract] [Full Text] [Related]

  • 13. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis.
    Lv SY, Wu Q, Liu JP, Shao J, Wen LL, Xue J, Zhang XS, Zhang QR, Zhang X.
    World Neurosurg; 2018 Mar; 111():e362-e373. PubMed ID: 29277532
    [Abstract] [Full Text] [Related]

  • 14. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial.
    Singh N, Hopkins SJ, Hulme S, Galea JP, Hoadley M, Vail A, Hutchinson PJ, Grainger S, Rothwell NJ, King AT, Tyrrell PJ.
    J Neuroinflammation; 2014 Jan 03; 11():1. PubMed ID: 24383930
    [Abstract] [Full Text] [Related]

  • 15. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E, López-Armada MJ, Fernández-Sueiro JL, Lema B, Galdo F, Blanco FJ.
    J Rheumatol; 2001 Dec 03; 28(12):2692-9. PubMed ID: 11764219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.
    Nakahara T, Tsuruta R, Kaneko T, Yamashita S, Fujita M, Kasaoka S, Hashiguchi T, Suzuki M, Maruyama I, Maekawa T.
    Neurocrit Care; 2009 Dec 03; 11(3):362-8. PubMed ID: 19777384
    [Abstract] [Full Text] [Related]

  • 18. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, McMurray TJ.
    Cytokine; 2002 Jan 21; 17(2):61-5. PubMed ID: 11886172
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage.
    Gueorguieva I, Clark SR, McMahon CJ, Scarth S, Rothwell NJ, Tyrrell PJ, Hopkins SJ, Rowland M.
    Br J Clin Pharmacol; 2008 Mar 21; 65(3):317-25. PubMed ID: 17875190
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, Kamei Y, Shimamura T, Suzuki T, Taniguchi S, Yoshida M.
    J Med; 1996 Mar 21; 27(1-2):57-71. PubMed ID: 8863178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.